Current Cancer Drug Targets, Volume 10 - Number 2

ROCK Inhibitors as Emerging Therapeutic Candidates for Sarcomas

, 10(2): 127 - 134

S. Micuda, D. Rosel, A. Ryska and J. Brabek

DOI: 10.2174/156800910791054202

Understanding FOXO, New Views on Old Transcription Factors

, 10(2): 135 - 146

F. Zanella, W. Link and A. Carnero

DOI: 10.2174/156800910791054158

Pharmacological Modulation of Genome and Proteome Alterations in Mice Treated with the Endocrine Disruptor Bisphenol A

, 10(2): 147 - 154

A. Izzotti, M. Longobardi, C. Cartiglia, F. D'Agostini, S. Kanitz and S. De Flora

DOI: 10.2174/156800910791054220

Dexamethasone Synergizes with Lenalidomide to Inhibit Multiple Myeloma Tumor Growth, But Reduces Lenalidomide-Induced Immunomodulation of T and NK Cell Function

, 10(2): 155 - 167

A. K. Gandhi, J. Kang, L. Capone, A. Parton, L. Wu, L. H. Zhang, D. Mendy, A. Lopez-Girona, T. Tran, L. Sapinoso, W. Fang, S. Xu, G. Hampton, J. B. Bartlett and P. Schafer

DOI: 10.2174/156800910791054239

Ras-Induced Resistance to Lapatinib is Overcome by MEK Inhibition

, 10(2): 168 - 175

G. Zoppoli, E. Moran, D. Soncini, M. Cea, A. Garuti, I. Rocco, G. Cirmena, V. Grillo, L. Bagnasco, G. Icardi, F. Ansaldi, S. Parodi, F. Patrone, A. Ballestrero and A. Nencioni

DOI: 10.2174/156800910791054211

Gefitinib Targets EGFR Dimerization and ERK1/2 Phosphorylation to Inhibit Pleural Mesothelioma Cell Proliferation

, 10(2): 176 - 191

R. E. Favoni, A. Pattarozzi, M. Lo Casto, F. Barbieri, M. Gatti, L. Paleari, A. Bajetto, C. Porcile, G. Gaudino, L. Mutti, G. Corte, T. Florio and M. Casto

DOI: 10.2174/156800910791054130

Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors

, 10(2): 192 - 199

S. Colombo, A. Palmioli, C. Airoldi, R. Tisi, S. Fantinato, S. Olivieri, L. De Gioia, E. Martegani and F. Peri

DOI: 10.2174/156800910791054185

Anti-GD2 Antibody Therapy for GD2-Expressing Tumors

, 10(2): 200 - 209

F. Navid, V. M. Santana and R. C. Barfield

DOI: 10.2174/156800910791054167

Inhibitors of HDACs - Effective Drugs Against Cancer?

, 10(2): 210 - 228

S. Muller and O. H. Kramer

DOI: 10.2174/156800910791054149

Antitumor Effect of Butanoylated Heparin with Low Anticoagulant Activity on Lung Cancer Growth in Mice and Rats

, 10(2): 229 - 241

Lunyin Yu, Hari G. Garg, Boyangzi Li, Robert J. Linhardt and Charles A. Hales

DOI: 10.2174/156800910791054176

The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery

, 10(2): 242 - 267

M. Hingorani, C. Spitzweg, G. Vassaux, K. Newbold, A. Melcher, H. Pandha, R. Vile and K. Harrington

DOI: 10.2174/156800910791054194

Webmaster Contact:
Copyright © 2018 Bentham Science